Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen vs Tamoxifen + Antioxidants for Male Infertility
NCT05200663Phase 2Unknown
- Sponsor
- Sharif Medical Research Center
- Start
- Oct 2021
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tamoxifen in male infertility, oligoasthenoteratozoospermia (OATS), sponsored by Sharif Medical Research Center. Status: unknown.
02
Drugs
tamoxifen
03
Conditions
male infertilityoligoasthenoteratozoospermia (OATS)
Beyond the preview
Go deeper on NCT05200663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05200663.